Pharmacology
Health

Immune cells increase pain from nerve damage
Immune cells increase chronic pain from nerve damage
By Redação
Chemistry

Collaboration to fight drug resistance
Seven pharmaceutical companies pledge to share surveillance data on antimicrobial resistance
By Redação
PUBLIC SPENDING

SUS to save money as patent extensions come to an end
Expenditure on nine drugs could be reduced by R$3.9 billion, according to UFRJ estimates
COVID-19

Anti-coronavirus semiconductors
Nanotechnological materials emerge as promising alternatives in the battle against SARS-CoV-2 and future pandemics
By Suzel Tunes
photolab

Light sensors
In the lab, zebrafish larvae become covered in green glowing dots when exposed to certain drugs or pollutants
By Redação
Health

Nasal COVID-19 vaccine
Research into intranasal vaccines against Covid-19 is advancing
By Redação
COVID-19

New coronavirus drugs
Pharmaceuticals announce orally administered drugs designed to treat the disease caused by SARS-Cov-2
By Tiago Jokura
Health

Focus on the bacillus
Fast, portable, and sensitive, a new test could be a useful tool for preventing leprosy and helping with early diagnosis.
By Tiago Jokura
Covid-19

New COVID-19 drug
An antiviral pill developed by pharmaceutical company Pfizer reduced the risk of death and hospitalization in people recently diagnosed with Covid-19 by 89% compared to a placebo
By Redação
COVID-19

Two vaccines safe for children
The CoronaVac vaccine, produced in Brazil by the Butantan Institute, is safe for children and adolescents, with no major side effects
By Redação
Pharmacology

University of Oxford in Brazil
The Brazilian Ministry of Health signed a term of commitment with the University of Oxford, UK, to establish a clinical research and development center in Rio de Janeiro for the British institution’s drugs and vaccines
By Redação
Nuclear medicine

Radiopharmaceuticals under threat
Radiopharmaceutical crisis leads to debate over production model
HEALTH

Pioneering immunization
Malaria vaccine recommended for children in Africa by the WHO is the first to protect humans from a parasite
By Tiago Jokura
Covid-19

A promising antiviral
Molnupiravir reduced COVID-19’s hospitalization and death rate by nearly half in a phase 3 clinical trial of people with mild to moderate infections
By Redação
COVID-19

Still too soon for booster doses
An international group of scientists argued against the idea of giving the majority of the population COVID-19 vaccine booster doses
By Redação
Physics/Chemistry

Free passage through the skin
Simulations indicate that applying an electric field stimulates the formation of "blisters" that turn the epidermis into a gateway for drugs to enter the body
By Tiago Jokura
COVID-19

ButanVac clinical trials begin
ButanVac, the vaccine candidate that will be produced by the Butantan Institute entirely in Brazil with no need to import any ingredients, has begun clinical trials
By Redação
Pharmacology

New Alzheimer’s drug sparks controversy
A new compound designed to fight Alzheimer's disease is causing controversy
By Redação